BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 43.21
+2.83 (7.01%)
At close: Jun 18, 2026
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 18.81 billion as of June 18, 2026. Its market cap has decreased by -8.42% in one year.
Market Cap
18.81B
Enterprise Value
20.87B
Revenue
1.30B
Ranking
n/a
PE Ratio
369.85
Stock Price
43.21
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 18.81B, an increase of 49.85%. That is a compound annual growth rate of 6.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 18.81B | -9.32% |
| Dec 31, 2025 | 20.74B | 62.70% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Zhifei Biological Products | 29.23B |
| Beijing Tiantan Biological Products | 24.34B |
| Hebei Changshan Biochemical Pharmaceutical | 23.76B |
| Suzhou Zelgen Biopharmaceuticals | 23.74B |
| Hualan Biological Engineering | 23.46B |
| Xiamen Amoytop Biotech | 22.79B |
| Yili Chuanning Biotechnology | 18.78B |
| Sinocelltech Group | 16.07B |